A recent legal case hinged on how a fiduciary relationship affects the official time limit on when clients can sue their advisors. Here's what happened.

Pharmaceutical companies should be required to regularly report whether theres a link between drug-pricing strategies and executive-compensation plans, according to a shareholder group.

The number of families selecting plans was up 1 percent from the total for the comparable period in 2016, but the total number of people on those coverage applications was down 4.2 percent, according to CMS data.

More companies are turning to the insights data analytics can provide to their businessand voluntary benefit manufacturers are no exception.